The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
Rituximab Reactive gastropathy 1
Rituximab Rectal adenocarcinoma 1
Rituximab Red blood cell abnormality 1
RITUXIMAB Red blood cell count decreased 1
RITUXIMAB Renal vein thrombosis 1
Rituximab Restrictive cardiomyopathy 1
RITUXIMAB Rheumatoid vasculitis 1
RITUXIMAB Rotavirus infection 1
RITUXIMAB Screaming 1
Rituximab Secondary immunodeficiency 1
RITUXIMAB Sensory loss 1
RITUXIMAB Skin disorder 1
RITUXIMAB Skin neoplasm excision 1
Rituximab Sleep apnoea syndrome 1
RITUXIMAB Soft tissue infection 1
rituximab Somnolence 1
RITUXIMAB Speech disorder 1
Rituximab Spinal column injury 1
RITUXIMAB Splenic infarction 1
Rituximab Staphylococcal sepsis 1

Total Records: 1,104     Number of Pages: 56